#MARKSANS BUY MODE TGT 49/76 SL 29
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
MARKSANS
34
-1.4 (-3.95%)
Updated 03:29 03/07 IST
MARKSANS Buy or Sell - FrontPage Forums
0 Users have submitted 0 trade ideas of Rs. 0 for MARKSANS
Disclaimer0% Bullish
0% Bearish
MARKSANS Buy or Sell - Brokerage Reports
No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
MARKSANS Ratings
Long term MARKSANS rating by FrontPage users
- ★★
- ★★
- ★★
- ★★
- ★★
0/5 (0 Ratings)0
Find answers to all your questions on live MARKSANS message board: Is MARKSANS buy or sell? Should I buy MARKSANS shares? Why are MARKSANS shares falling? Should I invest in MARKSANS stock?
- Home
- MARKSANS Forum
MARKSANS Share Price Discussion
N
Reputation: 3,432 • Jun 8 9:21 AM
Marksans Pharma recalls 11,279 bottles of diabetes drug due to cancer causing chemical
The company has issued voluntary recall of one batch of Metformin extended release tablets (USP 500 mg) due to detection of NDMA (N-nitrosodimethylamine), Marksans Pharma said in a regulatory filing.
The company has issued voluntary recall of one batch of Metformin extended release tablets (USP 500 mg) due to detection of NDMA (N-nitrosodimethylamine), Marksans Pharma said in a regulatory filing.
The Economic Times
Like
Reply
N
Reputation: 3,432 • Jun 8 7:18 AM
Marksans Pharma recalls 11,279 bottles of diabetes drug due to cancer causing chemical
The company has issued voluntary recall of one batch of Metformin extended release tablets (USP 500 mg) due to detection of NDMA (N-nitrosodimethylamine), Marksans Pharma said in a regulatory filing.
The company has issued voluntary recall of one batch of Metformin extended release tablets (USP 500 mg) due to detection of NDMA (N-nitrosodimethylamine), Marksans Pharma said in a regulatory filing.
Moneycontrol
Like
Reply
#
Reputation: 30,514 • Jun 2 4:47 AM
BUY MARKSAN PHARMA @ 25-26, STRICT SL 23, TGT 35-40 ( 8-10 day #MARKSANS
Like
Reply
N
Reputation: 3,432 • Feb 11 6:38 AM
Marksans Pharma gets EIR from USFDA for New York unit
In a regulatory filing, the company announced "receipt of the EIR from US Food and Drug Administration (USFDA) in respect of inspection of company's manufacturing facility Time-Cap Laboratories Inc. located at Farmingdale, New York, USA carried out from December 5, 2019 to December 18, 2019".
In a regulatory filing, the company announced "receipt of the EIR from US Food and Drug Administration (USFDA) in respect of inspection of company's manufacturing facility Time-Cap Laboratories Inc. located at Farmingdale, New York, USA carried out from December 5, 2019 to December 18, 2019".
Moneycontrol
Like
Reply
N
Reputation: 3,432 • Jun 6, 2019 10:08 AM
An evening walk down D-St: Lack of any major step for NBFC crisis pulls Sensex 550 pts lower
Like
Reply
N
Reputation: 3,432 • Jun 6, 2019 9:38 AM
Marksans Pharma rallies 5% after Goa unit receives EIR from USFDA
Like
Reply
N
Reputation: 3,432 • Mar 7, 2019 7:52 AM
Marksans Pharma slips 4% post USFDA inspection at Goa facility
Like
Reply
C
Reputation: 262 • Feb 11, 2019 1:39 AM
Marksans Pharma reported better than street estimates of Q3 results. Company reported Q3 net profit Rs251.3mn (up 44% YoY), EBITDA margin 14.5% vs 13.2% (QoQ) and sales Rs2.48bn (up 14% YoY)
Like
Reply
N
Reputation: 3,432 • Nov 17, 2018 10:47 AM
These 10 stocks moved between 10-35%: Do you own any?
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
- keyboard_arrow_down
MARKSANS Share Price - Technicals
- NewsBotJun 8 9:21 AMMarksans Pharma recalls 11,279 bottles of diabetes drug due to cancer causing chemicalThe Economic TimesNewsBotJun 8 7:18 AMMarksans Pharma recalls 11,279 bottles of diabetes drug due to cancer causing chemicalMoneycontrolNewsBotFeb 11 6:38 AMMarksans Pharma gets EIR from USFDA for New York unitMoneycontrolNewsBotJun 6, 2019 10:08 AMAn evening walk down D-St: Lack of any major step for NBFC crisis pulls Sensex 550 pts lowerNewsBotJun 6, 2019 9:38 AMMarksans Pharma rallies 5% after Goa unit receives EIR from USFDANewsBotMar 7, 2019 7:52 AMMarksans Pharma slips 4% post USFDA inspection at Goa facilityNewsBotNov 17, 2018 10:47 AMThese 10 stocks moved between 10-35%: Do you own any?
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.